Answers are grounded in this paper and cite their sources.
Novel bilayer coating eliminates bacterial infection on surfaces, enhancing safety across various applications.
Bacterial anchoring and biofilm formation on engineering substrates cause severe medical and food-safety infections. We report a novel phase-transited lysozyme/polydopamine (PDTL) composite bilayer coating that eliminates these bottlenecks by coupling enzymatic hydrolysis with photothermal cleansing. The bottom polydopamine (PDA) layer provides robust interfacial anchoring and near-infrared photothermal shearing capabilities. Meanwhile, the highly transparent top phase-transited lysozyme (PTL) layer self-assembles via β-sheet-oriented stacking, preserving its chemical bactericidal activity. This structural architecture seamlessly synergizes localized physical heat dissipation with active bio-macromolecular lysis, achieving an exceptional 99.9% bactericidal efficiency while maintaining excellent mammalian cytocompatibility. Furthermore, cross-interface simulations demonstrate high material adaptability across diverse operational substrates, including polyethylene packaging polymers, clinical catheters, and medical sponges. This scalable, biomolecule-based strategy provides a spatiotemporally controllable, safe, and highly efficient design philosophy for advanced anti-infection interface engineering.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: